| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
|
Saygin, Caner
|
|
|
7 |
4 |
p. 549-554
|
artikel
|
| 2 |
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study
|
Kemps, Paul G.
|
|
|
7 |
4 |
p. 664-679
|
artikel
|
| 3 |
Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
|
Elalfy, Mohsen S.
|
|
|
7 |
4 |
p. 611-619
|
artikel
|
| 4 |
Disruption of stem cell niche–confined R-spondin 3 expression leads to impaired hematopoiesis
|
Kurtova, Antonina V.
|
|
|
7 |
4 |
p. 491-507
|
artikel
|
| 5 |
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment
|
Lai, Catherine
|
|
|
7 |
4 |
p. 529-532
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
7 |
4 |
p. i
|
artikel
|
| 7 |
Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
|
Girgis, Suzette
|
|
|
7 |
4 |
p. 644-648
|
artikel
|
| 8 |
Elucidating parasite and host-cell factors enabling Babesia infection in sickle red cells under hypoxic/hyperoxic conditions
|
Beri, Divya
|
|
|
7 |
4 |
p. 649-663
|
artikel
|
| 9 |
EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress
|
Kikuchi, Jiro
|
|
|
7 |
4 |
p. 508-524
|
artikel
|
| 10 |
Front Matter
|
|
|
|
7 |
4 |
p. ii
|
artikel
|
| 11 |
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
|
Mazzara, Saveria
|
|
|
7 |
4 |
p. 630-643
|
artikel
|
| 12 |
Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study
|
Gagelmann, Nico
|
|
|
7 |
4 |
p. 555-559
|
artikel
|
| 13 |
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium
|
Stefanski, Heather E.
|
|
|
7 |
4 |
p. 541-548
|
artikel
|
| 14 |
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort
|
Reda, Gianluigi
|
|
|
7 |
4 |
p. 525-528
|
artikel
|
| 15 |
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial
|
Burke, G. A. Amos
|
|
|
7 |
4 |
p. 602-610
|
artikel
|
| 16 |
Interferon-γ blockade in CAR T-cell therapy–associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis
|
Rainone, Michael
|
|
|
7 |
4 |
p. 533-536
|
artikel
|
| 17 |
Jeong H, Cho H, Kim H, et al. Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis. Blood Adv. 2021;5(8):2142-2152.
|
|
|
|
7 |
4 |
p. 560
|
artikel
|
| 18 |
Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma
|
Edwards, Camille V.
|
|
|
7 |
4 |
p. 482-490
|
artikel
|
| 19 |
Platelet-targeted thrombolysis for treatment of acute ischemic stroke
|
Palazzolo, Jason S.
|
|
|
7 |
4 |
p. 561-574
|
artikel
|
| 20 |
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
|
Lamble, Adam J.
|
|
|
7 |
4 |
p. 575-585
|
artikel
|
| 21 |
Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists
|
Drillet, Gaëlle
|
|
|
7 |
4 |
p. 537-540
|
artikel
|
| 22 |
RNA-regulatory exosome complex suppresses an apoptotic program to confer erythroid progenitor cell survival in vivo
|
Fraga de Andrade, Isabela
|
|
|
7 |
4 |
p. 586-601
|
artikel
|
| 23 |
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma
|
Heynen, Guus J. J. E.
|
|
|
7 |
4 |
p. 469-481
|
artikel
|
| 24 |
The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A
|
Male, Christoph
|
|
|
7 |
4 |
p. 620-629
|
artikel
|
Tijdschrift beschrijving